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Summary
Magnetic resonance imaging (MRI) provides an opportunity for identifying peri‐
ictal MRI abnormalities (PMAs) related to status epilepticus (SE). Extremely vari-
able MRI alterations have been reported previously during or after SE, mainly in
small selected populations. In a retrospective monocentric study, we analyzed
brain MRI changes observed in the ictal/postictal periods of SE in an adult popu-
lation. We included all consecutive patients observed in a 5‐year period with an
electroclinical diagnosis of SE and an MRI performed within 30 days from the
beginning of SE. We identified 277 patients. Among them, 32 (12%) showed
PMAs related to SE. The duration of SE was strongly associated with MRI alter-
ations, showing a mean duration of 6 days vs 2 days (P = .011) in the group with
and without MRI alterations, respectively. Focal electroencephalography (EEG)
abnormalities (P = .00003) and in particular, lateralized periodic discharges
(LPDs) (P < .0001) were strongly associated with PMAs. MRI alterations were
unilateral (23 patients, 72%), located in multiple brain structures (19 patients,
59%), and involving mesiotemporal structures (17 patients, 53%). Sixteen patients
(50%) had good spatial correspondence between cortical PMAs and the focal EEG
pattern; 12 patients (38%) with focal EEG pattern showed cortical PMAs plus
MRI signal changes also involving subcortical structures. A follow‐up MRI was
available for 14 of 32 patients (44%): 10 patients presented a disappearance of
PMAs, whereas in 4, PMAs were still present. This study demonstrates that a long
duration SE and the presence of certain EEG patterns (LPDs) are associated with
the occurrence of PMAs. A good spatial concordance was observed between corti-
cal PMA location and the EEG focus.
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1 | INTRODUCTION
Status epilepticus (SE) is conceptually defined as “a condi-
tion resulting either from the failure of the mechanisms
responsible for seizure termination or from the initiation of
mechanisms, which lead[s] to abnormally, prolonged sei-
zures (after time point t1). It is a condition, which can have
long‐term consequences (after time point t2), including
neuronal death, neuronal injury, and alteration of neuronal
networks, depending on the type and duration of sei-
zures.”1 This new definition underscores the pathophysio-
logic mechanisms that sustain SE development and its
maintenance, thereby increasing the risk of neuronal
injury.2
Ongoing seizure activity is accompanied by an
excessive release of glutamate, which activates postsynap-
tic N‐methyl‐D‐aspartate (NMDA) receptors and triggers
receptor‐mediated calcium influx. This leads to desensiti-
zation and internalization of postsynaptic γ‐aminobutyric
acid A (GABA‐A) receptors3 and increased expression of
proconvulsive neuropeptides,4,5 creating a vicious cycle of
self‐sustained seizure. Calcium influx also causes a cas-
cade of biochemical changes, mitochondrial dysfunction,
oxidative stress6 modification of gene expression, and ini-
tiation of cell death.7 At the same time, the sustained sei-
zure activity increases cerebral glucose metabolism,
oxygen and adenosine triphosphate (ATP) depletion, and
lactate accumulation, finally leading to hypermetabolic
neuronal necrosis.8
Magnetic resonance imaging (MRI) provides an oppor-
tunity for early identification of alterations related to sei-
zures activity. Variable periictal MRI alterations9,10
(PMAs) have been reported in patients with SE, in either
the ictal or the postictal period. Restricted diffusion (high
signal in diffusion‐weighted imaging [DWI] sequences and
corresponding low apparent diffusion coefficient, ADC)9,11
and hyper‐intensities in T2‐weighted and fluid‐attenuated
inversion recovery (FLAIR) sequences that could even
appear simultaneously,12 are the most frequently encoun-
tered alterations. These changes represent a continuum of
cytotoxic (increased DWI and decreased ADC signal) and
vasogenic edema (increased DWI and increased T2 without
decreased ADC signal) mostly depending on the timing of
MRI performance.9,10 Rarely a T2 hypointensity can be
seen in patients with ongoing SE.9 Moreover, ictal hyper-
perfusion in MR perfusion (MRP) sequences,11 correspond-
ing increased vascularity in MR angiography (MRA), and
contrast enhancement, which are co‐localized with afore-
mentioned alterations, may be seen.9,13,14
PMAs have been observed in different cortical
areas,9,15–17 as well as involving subcortical structures. Pre-
vious studies also highlighted some preferential
susceptibility regions or networks: the mesolimbic struc-
tures,9,10,15,18 the pulvinar nucleus of thalamus,13,18,19 the
splenium of corpus callosum,18,20 the contralateral cerebel-
lum (a sign known as crossed cerebellar diaschi-
sis),13,18,21,22 the insular cortex and basal ganglia,9,13 and
the claustrum.10,23 The majority of these cases had focal
SE18,24 and showed PMAs both locally, in the cortical area
of the ictal activity, as well as in remote cortical or subcor-
tical areas generally believed to represent regions involved
by ictal activity at the network level (eg, the thalamus and
ipsilateral pulvinar).12,18,19 Moreover, lateralized periodic
discharges (LPDs) plus seizures seem to be associated with
the development of acute/subacute DWI alterations.25
These MRI changes can be completely reversible,
although their exact appearance or disappearance timing is
unknown20 and is variable among different patients.12 The
changes can even persist and be followed by permanent
alterations such as cortical laminar necrosis, mesial tempo-
ral sclerosis,10,26 and focal brain atrophy.9,13
2 | PURPOSE
The MRI changes associated with SE have been described,
but the reports in the literature are scarce and based mainly
on small selected populations. There are only a few studies
correlating MRI changes with electroclinical patterns in SE.
Therefore, we aimed to identify and stratify the patterns of
PMA associated with SE and to correlate them with elec-
troclinical features of SE in a large series of adult patients.
3 | METHODS
3.1 | Inclusion criteria and adopted
definitions
This is a retrospective monocentric study on an adult SE
population studied with a brain MRI in the ictal/postictal
period of SE.
Key Points
• MRI is a useful, noninvasive, and easily avail-
able tool for identifying acute/subacute SE
related alterations
• A long duration of SE with LPDs is strongly
associated with periictal MRI abnormalities
• Acute/subacute MRI changes are generally rever-
sible, but long-term, permanent consequences
could be generated
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Status epilepticus (or SE) was defined as a continuous
seizure or 2 or more discrete seizures between which there
is no complete recovery of consciousness, that lasts
≥5 minute for convulsive SE (CSE) and more than 10 min-
utes in nonconvulsive status epilepticus (NCSE).1
The inclusion criteria were the following: (1) an electro-
clinical diagnosis of SE, (2) an MRI that included all
sequences of the hospital SE protocol, and (3) MRI per-
formed within 30 days of the beginning of SE.
3.2 | Enrollment strategies
We searched the clinical and EEG database of the Depart-
ment Neurology, Christian Doppler Klinik, Paracelsus
Medical University, Salzburg, Austria, between 01.01.2011
and 31.12.2015 (see Figure 1).
3.3 | MRI study protocol and analysis
All included patients underwent high‐resolution MRI (3‐
Tesla; Philips Achieva Stream, Andover, Massachusetts)
using the standard protocol for SE patients routinely used
at our institution. MRI sequences included T1‐weighted 3‐
dimensional isovoxel (1 × 1 × 1 mm) turbo field echo
images with (when needed) and without intravenous con-
trast application, axial and coronal T2‐weighted turbo spin
echo, T2‐weighted FLAIR, and DWI sequences. Coronal
T2‐weighted (2 mm) and FLAIR slices were 2.35 mm
thick and were acquired at 90 degrees perpendicular to the
long axis of hippocampus.
The acute/subacute MRI scans were reviewed indepen-
dently by 2 raters who judged for the presence/absence of
MRI's alterations related to SE. Whenever there was any
discordance, a third rater was consulted. Finally, for the
patients with PMAs, we searched for and analyzed the fol-
low‐up MRIs whenever present.
3.4 | EEG study details and clinical data
collection
Using informatics databases, for each included SE episode
we collected clinical information such as age, gender, and
type of treatment. Each SE episode was classified in rela-
tion to etiology, duration, clinical manifestations, response
to treatment, and EEG characteristics too.
The EEGs were acquired using the international 10‐20
system. Each EEG recording lasted for at least 20 minutes
and was assessed by board‐certified neurophysiologists.
3.5 | Statistical analysis
Statistical analysis was performed using SPSS Statistics
23.0 (2015; IBM Corporation, Armonk, New York).
Descriptive statistics were used to analyze and compare
clinical and demographic variables in the whole popula-
tion and in subgroups divided according to the presence/
absence of PMAs.
Categorical data were analyzed by means of 2 × 2 χ2
test with Yates correction. Two‐by‐two comparisons were
performed by means of the Mann‐Whitney test. Inter‐rater
agreement for identifying SE‐associated MRI alterations
was assessed using Cohen’s kappa coefficient (κ).
FIGURE 1 Selection process flowchart. We initially identified
1449 patients with either suspected or definite diagnosis of SE.
Medical records of each patient were thereafter meticulously
analyzed. We excluded 554 patients because, despite the initial
suspicion, these patients did not have SE. Of the 895 selected SE
cases, 286 (32%) underwent brain MRI scan in the first 30 days from
the beginning of SE, and thus they were included in the study. For
each included patient we reviewed brain MRI results, EEG
recordings, and medical records: 2 patients were thereafter excluded
because of lack of clinical information and 7 patients were excluded
due to either presence of MRI artifacts that interfered with the
analysis or because they received an incomplete MRI study. At the
end of the search 277 patients fulfilled the criteria and were included
in the study
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Univariate logistic regression analysis was conducted to
identify significant associations of each clinical variable
with the presence of PMAs. The statistical significance cut‐
off was set at .05.
4 | RESULTS
4.1 | Population's demographic
characteristics
In the studied population (n = 277), 58% were male with a
mean age of 63 years (ranging from 13 to 90 years).
Thirty‐two of them (12%) showed PMAs related to SE (see
Table 1).
4.2 | SE clinical characteristics
The demographic and clinical characteristics of the patients
are shown in Table 1. In the whole population, the most
common SE etiologies were brain tumors (21%), SE in a
previously diagnosed epilepsy (16%), and chronic cere-
brovascular disease (11%). Only inflammatory/autoimmune
etiology (odds ratio [OR] 4.23, confidence interval [CI]
1.20‐14.96) and sepsis (OR 8.1, CI 1.1‐59.63) were associ-
ated with PMAs.
The majority of patients (73%) presented with NCSE,
either as the evolution form from previous motor manifes-
tations or as the only semiology of the SE episode. Gener-
alized convulsive status epilepticus (GCSE) evolving into
NCSE with coma was associated with the presence of
PMAs (OR 5.00, CI 1.83‐13.68).
Finally, the duration of the SE itself was the strongest
observed association with the appearance of PMAs.
Indeed, patients with SE‐related MRI alterations, had a
SE mean duration of 6 days (mean duration of refractory
status epilepticus/super‐refractory status epilepticus (RSE/
SRSE): 9.2 days; mean duration of RSE: 5.4 days),
whereas patients without PMAs had a mean SE duration
of 2 days (mean duration of RSE/SRSE: 7.5 days; mean
duration of responsive SE: 1.2 days) (P = .011). Only
27% of patients without MRI alterations had a SE lasting
≥48 hours compared to 59% with MRI alterations
(P = .0003).
4.3 | EEG characteristics
In patients with PMA, focal EEG patterns were more often
(P = .00003, OR 21.25, CI 2.85‐158.22) than diffuse ictal
EEG ones (P = .0002, OR 0.06, CI 0.008‐0.44).
Lateralized periodic discharges (or LPDs) were present
in 47% of patients with PMAs vs 13% of patients in whom
MRI changes were not seen (P < .0001, OR 5.76, CI 2.62‐
12.67).
In the whole population, 97 patients received MRI dur-
ing SE. Among them, 24 had LPD activity and 73 did not.
Nine patients of 73 without LPD activity (12%), showed
PMAs, whereas 11 of 24 with LPD activity (46%) had
PMAs (P < .001).
Conversely, 172 patients were imaged after the end of
SE. Among them 149 did not have LPD activity on the
previous EEG, whereas 23 had LPDs in any of the EEG
recorded during the SE. Eight of 149 patients without
LPDs (6%) had PMA, whereas 4 of 23 with LPDs (17%)
showed PMA (P < .035).
Notably, the presence of LPDs and SE duration showed
a “synergistic” effect on PMAs. Indeed, the median dura-
tion of SE in patients with LPDs and PMA was 11 days,
whereas SE duration in patients with LPDs but without
PMAs was 1 day.
4.4 | Timing of MRI study
In the majority (63%), MRI was performed after SE has
ended. Among patients with SE‐related MRI alterations, 20
of 32 patients (63%) had the investigation while SE was
still ongoing, whereas only 78 of 245 patients (32%) with-
out SE‐related MRI alterations underwent MRI during the
SE (P = .001).
4.5 | Classification of SE‐related MRI
changes
Inter‐rater agreement for identifying SE‐associated MRI
alterations was very high (Cohen's kappa .818). An
increased signal in DWI and ADC with or without corre-
spondent hyperintensities in T2/FLAIR sequences was seen
in 11 patients (34%); 14 patients (44%) presented with an
increased signal in DWI and a correspondent decreased
ADC value with or without hyperintensities in T2/FLAIR
sequences; the remaining 7 patients presented an increased
signal on DWI, but for them the ADC map was not avail-
able (see Table 2).
Either unilateral (23 patients, 72%) or bilateral (9
patients, 28%) changes could be seen on MRI. In 19
patients (59%), alterations were observed in multiple brain
structures either affected alone or as part of a more exten-
sive circuit: (1) mesiotemporal structures (17 patients,
53%); (2) pulvinar nucleus of the thalamus (16 patients,
50%); (3) neocortex (15 patients, 47%): frontal and tempo-
ral cortices in 6 cases each, parietal cortex—in 5 cases and
occipital cortex—in 1 case; and (4) insula (7 patients,
22%). Sixteen patients (50%) showed alterations involving
the neocortex or mesiotemporal structures alone. In 13
patients (41%), cortical and deep structures (thalamus) were
involved. In 3 patients (9%), MRI changes were found only
in the thalamus.
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4.6 | Correlation of EEG and MRI features
PMAs were well co‐localized with focal EEG ictal dis-
charges in 16 patients (50%). Twelve patients (38%) had
focal ictal activity on EEG, and MRI changes involving
local structures corresponding to the site of the highest
EEG activity plus subcortical structures (unilateral or bilat-
eral changes in the pulvinar nucleus of the thalamus).
Only 3 patients (9%) presented focal ictal activity on
EEG and isolated deep homolateral thalamus involvement
TABLE 1 Demographic and clinical variables of the patients
Clinical characteristics of included patients
All
included
patients
Patients
without
PMAs
Patients
with
PMAs
P
n 277 (n, %) 245 (n, %) 32 (n, %)
Gender (M) 160 58% 143 58% 17 53% .572
Average age
(years)
62.5 63.0 59.3 .233
Type of SE
NCSE 168 61% 150 61% 18 56% .588
GCSE—
NCSE
20 7% 13 5% 7 22% .001
FMSE—NCSE 8 3% 7 3% 1 3% .932
GCSE 43 16% 40 16% 3 9% .307
FMSE 30 11% 27 11% 3 9% .778
MSE 8 3% 8 3% 0 0% .3
SE duration
Average (days) 2 2 6 .011
≥48 h 85 31% 66 27% 19 59% <.001
Etiology
Acute CVD 25 9% 23 9% 2 6% .56
Chronic CVD 30 11% 26 11% 4 13% .747
Alcohol related 2 1% 2 1% 0 0% .608
Anoxia 27 10% 27 11% 0 0% .05
Brain trauma 10 4% 9 4% 1 3% .876
Inflammatory/
autoimmune
12 4% 8 3% 4 13% .016
Dementia 3 1% 3 1% 0 0% .529
Hydrocephalus 2 1% 2 1% 0 0% .608
Metabolic
alterations
24 9% 18 7% 6 19% .11
Infectious
encephalitis
12 4% 11 4% 1 3% .721
Sepsis 4 1% 2 1% 2 6% .015
Brain neoplasm 58 21% 54 22% 4 13% .212
Perinatal injuries 7 3% 7 3% 0 0% .333
Epilepsy related 45 16% 41 17% 4 13% .541
Cryptogenic 16 6% 12 5% 4 13% .104
Treatment response
Responsive SE 229 83% 204 83% 25 78% .47
RSE 18 6% 16 7% 2 6% .952
SRSE 30 11% 25 10% 5 16% .353
Bold values are statistically significant (P < .05). CVD, cerebrovascular disease;
FMSE, focal motor status epilepticus; GCSE, generalized convulsive status epilep-
ticus; MSE, myoclonic status epilepticus; NCSE, nonconvulsive status epilepticus;
RSE, refractory status epilepticus; SRSE, super‐refractory status epilepticus.
TABLE 2 MRI characteristics of the cohort
Patient no. DWI ADC T2 Flair
Post‐
contrast F‐UP
1 ↑ N/A ↑ ↑ N D
2 ↑ ↑ ↑ ↑ N/D D
3 ↑ ↓ N N N N/D
4 ↑ ↑ N/A N/A N D
5 ↑ N/A N/A N/A N/D N/D
6 ↑ ↑ N/A N/A N/D N/D
7 ↑ ↓ N N N/D N/D
8 ↑ ↓ N/A ↑ N/D D
9 ↑ ↓ ↑ ↑ N N/D
10 ↑ N/A ↑ ↑ N/D D
11 ↑ N/A N N N/D D
12 ↑ ↑ N/A N N N/D
13 ↑ ↓ ↑ ↑ N/D N/D
14 ↑ ↓ N N N N/D
15 ↑ ↑ N N N N/D
16 ↑ ↓ N/A N/A N/D N/D
17 N/A N/A ↑ ↑ N A
18 ↑ N/A N/A N/A N/D N/D
19 ↑ N/A N N N/D N/D
20 ↑ ↓ ↑ ↑ N D
21 ↑ ↑ ↑ ↑ N D
22 ↑ ↓ ↑ ↑ N/D N/D
23 ↑ ↓ ↑ ↑ N/D A
24 ↑ ↓ N/A ↑ N/D N/D
25 ↑ ↓ N/A ↑ N/D D
26 ↑ ↑ ↑ ↑ N/D A
27 ↑ ↓ ↑ ↑ N/D N/D
28 ↑ ↑ N N N N/D
29 ↑ ↑ ↑ ↑ N/D N/D
30 ↑ ↑ ↑ ↑ N N/D
31 ↑ ↓ N/A N N/D A
32 ↑ ↑ ↑ ↑ N D
↑, increased signal; ↓, reduced signal; A, attenuated; D, disappeared; N,
normal; NA, not accessible due to motion artifacts; ND, not done; Pt, patient.
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on the MRI without cortical alterations. On the other hand,
the only patient with a diffuse ictal pattern on EEG pre-
sented a diffuse bilateral involvement of insular cortex and
thalamus.
Among patients with LPDs, 6 (40%) presented with iso-
lated local MRI changes corresponding to the focus of
LPDs activity; 6 (40%) showed focal MRI changes together
with deep homolateral involvement of the pulvinar; 3
patients (20%) had isolated homolateral pulvinar involve-
ment (Figures 2-5).
4.7 | Follow‐up MRI evaluations
A follow‐up MRI was performed (9 days to 3.6 years after
the SE) in 14 of 32 patients (44%). MRI changes com-
pletely disappeared in 10 of 14 patients (71%), whereas in
the remaining 4 of 14 (29%), signal alterations were attenu-
ated but not completely resolved. No patients had
unchanged alterations.
5 | DISCUSSION
In this retrospective study on a large single‐center cohort,
we identified 32 patients (12%) with MRI changes related
to SE. The duration of the SE episode was the factor with
the highest significant association with the appearance of
PMAs. In addition, LPDs were strongly associated with
SE‐related MRI changes.
Incidence of SE‐related MRI signal alterations in retro-
spective series varies between 11.6% and 50%.18,27 In our
population, acute/subacute MRI changes were present in
only 12% of the patients studied with MRI during or after
an episode of SE. This low proportion is related mostly to
the fact that only 35% of the patients received an MRI
study during SE and most investigations were performed
after cessation of the study. Because these MRI changes
are supposedly caused by continuous or repetitive epileptic
activity, a higher proportion of patients with PMAs can be
FIGURE 2 A, DWI signal hyperintensity in the pulvinar of
thalamus on the right and in the right hippocampus. B, Continuous
quasi‐periodic spike and waves at frequency of 0.7‐1 Hz showing an
evolving pattern into a poly‐spikes at 4‐5 Hz on the right
frontotemporal leads
FIGURE 3 A, DWI and FLAIR signal hyperintensity in the right
parietal cortex. B, Continuous quasi‐periodic sharp waves at
frequency of 1 Hz on the right temporoparietal leads
FIGURE 4 A, Bilateral thalamic DWI hyperintensity. B, Diffuse
triphasic sharp waves at frequency of 1 Hz
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expected if MRI is performed during the SE instead of
after its cessation.24,28 Nevertheless, it is still possible to
find these alterations for some time after the end of SE; the
duration could depend on two factors: patient characteris-
tics (eg, age, comorbidities), or seizure characteristics (type
and duration of ictal activity).
Among all investigated clinical parameters, we identi-
fied a crucial role of SE duration: the longer the dura-
tion of SE, the higher the probability of finding SE‐
related MRI alterations.24,29 Moreover, these alterations
were mostly associated with the presence of LPDs. Thus,
long‐lasting SE with LPD activity is most frequently
associated with the presence of PMAs.25,30 LPDs were
present in patients with SE of various etiologies, such as
cerebrovascular, autoimmune, or infectious. In 4 patients,
PMAs were observed in the context of autoimmune
encephalitis. In these cases, the observed MRI alterations
can represent abnormalities related to the underlying eti-
ology not representing a consequence of the ictal activity
per se.
Our results indicate that PMAs well co‐localize with
either the epileptic focus or remote areas presumably
involved in the epileptic network,15 such as the cortical
connections to the pulvinar of the thalamus.19 Even if there
is a certain degree of susceptibility among different individ-
uals12 (variability in mitochondrial reserve in stress situa-
tions) and in the same individual among the different
cerebral areas, we confirmed that the mesiotemporal struc-
tures are highly susceptible to ictal damage, thus they were
most frequently involved.10,31
In the majority of our patients, PMA alterations were
transient,16 but because only a minority of our patients had
a follow‐up MRI we cannot draw any firm conclusion
about their role as a possible biomarker of permanent func-
tional and structural damage.
6 | STUDY LIMITATIONS AND
CONCLUSIONS
The most important limitations of the present study are its
retrospective nature and the low number of patients with
MRI acquired during SE itself. The number of follow‐up
MRI studies was also low and as it would be expected in a
retrospective study, the MRI were not performed at fixed
intervals but at highly different time points in the course of
SE or after its cessation. These limitations do not allow us
to attribute observed MRI alterations to SE per se. MRI
changes might be caused by the nature of the possible
underlying lesion such as limbic encephalitis or stroke. It is
challenging to disentangle the role of the underlying struc-
tural lesion, and we did not address this issue in the current
study, which could be better tackled in the prospective
design.
A prospective study with MRI performed during the SE
and at regular follow‐ups would also better define the rela-
tionship between the electroclinical characteristics and MRI
alteration patterns and the role of MRI in the early predic-
tion of long‐term consequences after SE.
In summary, in this retrospective study, PMAs were
observed mainly in association with prolonged SE and lat-
eralized epileptiform discharges on EEG. MRI alterations
affected different brain structures, involving mesiotemporal
in more than half of cases.
DISCLOSURE OF CONFLICT OF INTEREST
Prof. Trinka has acted as a paid consultant to Eisai, Ever
Neuropharma, Biogen, Sunovion, Bial, and UCB, has
received speakers’ honoraria from Bial, Eisai, GL Pharma,
GlaxoSmithKline, Boehringer, Viropharma, Actavis, New-
bridge, Sunovion, Novartis, Takeda, and UCB. Dr. Trinka
has received research funding from UCB Pharma, Biogen,
Red Bull, Merck, the European Union, FWF Österreichis-
cher Fond zur Wissenschaftsförderung, Bundesministerium
für Wissenschaft und Forschung, and Jubiläumsfond der
Ősterreichischen Nationalbank.
Prof. Meletti received research grant support from the
Ministry of Health (MOH) and from the nonprofit organi-
zation CarisMo Foundation; and has received personal
compensation as a scientific advisory board member for
UCB and Eisai. Prof Meletti has received speakers’ hono-
raria from UCB, Eisai, Sandoz. Dr Giovannini, Dr
FIGURE 5 A, DWI increased signal and correspondent ADC
restriction located in the left thalamus. B, Continuous quasi‐periodic
left hemispheric sharp waves at frequency of 0.8‐1 Hz
GIOVANNINI ET AL. | 7
Kuchukhidze, and Dr McCoy have no disclosures. We con-
firm that we have read the Journal's position on issues
involved in ethical publication and affirm that this report is
consistent with those guidelines.
ORCID
Stefano Meletti http://orcid.org/0000-0003-0334-539X
REFERENCES
1. Trinka E, Cock H, Hesdorffer D, et al. A definition and classifi-
cation of status epilepticus – report of the ILAE Task Force on
Classification of Status Epilepticus. Epilepsia. 2015;56:1515–23.
2. Duncan JS. Seizure‐induced neuronal injury: human data. Neurol-
ogy. 2002;59:S15–20.
3. Goodkin HP, Joshi S, Mtchedlishvili Z, et al. Subunit‐specific
trafficking of GABA‐A receptors during status epilepticus. J Neu-
rosci. 2008;28:2527–38.
4. Liu H, Mazarati AM, Katsumori H, et al. Substance P is
expressed in hippocampal principal neurons during status epilepti-
cus and plays a critical role in the maintenance of status epilepti-
cus. Proc Natl Acad Sci USA. 1999;96:5286–91.
5. Mazarati A, Liu H, Wasterlain C. Opioid peptide pharmacology
and immunocytochemistry in an animal model of self‐sustaining
status epilepticus. Neuroscience. 1999;89:167–73.
6. Cock H. The role of mitochondria in status epilepticus. Epilepsia.
2007;48(Suppl. 8):24–7.
7. Fujikawa DG. Prolonged seizures and cellular injury: understand-
ing the connection. Epilepsy Behav. 2005;7(Suppl. 3):S3–11.
8. Wasterlain CG, Fujikawa DG, Penix L, et al. Pathophysiological
mechanisms of brain damage from status epilepticus. Epilepsia.
1993;34(Suppl. 1):S37–53.
9. Cianfoni A, Caulo M, Cerase A, et al. Seizure‐induced brain
lesions: a wide spectrum of variability reversible MRI abnormali-
ties. Eur J Radiol. 2013;82:1964–72.
10. Cartagena AM, Young GB, Lee DH, et al. Reversible and irre-
versible cranial MRI findings associated with status epilepticus.
Epilepsy Behav. 2014;33:24–30.
11. Mendes A, Sampaio L. Brain magnetic resonance in status
epilepticus: a focused review. Seizure. 2016;38:63–7.
12. Cole AJ. Status epilepticus and periictal imaging. Epilepsia.
2004;45(Suppl 4):72–7.
13. Huang Y-C, Weng H-H, Tsai Y-T, et al. Periictal magnetic reso-
nance imaging in status epilepticus. Epilepsy Res. 2009;86:72–81.
14. Szabo K, Poepel A, Pohlmann-Eden B, et al. Diffusion‐weighted
and perfusion MRI demonstrates parenchymal changes in com-
plex partial status epilepticus. Brain. 2005;128:1369–76.
15. Kim J-A, Chung JI, Yoon PH, et al. Transient MR signal changes
in patients with generalized tonicoclonic seizure or status epilepti-
cus: periictal diffusion‐weighted imaging. AJNR. 2001;22:1149–
60.
16. Lansberg MG, O'Brien MW, Norbash AM, et al. MRI abnormali-
ties associated with partial status epilepticus. Neurology.
1999;52:1021–7.
17. Juha′sz C, Scheidl E, Szirmai I. Reversible focal MRI abnormali-
ties due to status epilepticus. An EEG, single photon emission
computed tomography, transcranial Doppler follow‐up study.
Electroencephalogr Clin Neurophysiol. 1998;107:402–7.
18. Milligan TA,ZamaniA,Bromfield E. Frequency and patterns ofMRI
abnormalitiesdue to statusepilepticus.Seizure. 2009;18:104–8.
19. Katramados AM, Burdette D, Patel SC, et al. Peri‐ictal diffusion
abnormalities of the thalamus in partial status epilepticus. Epilep-
sia. 2009;50:265–75.
20. Xiang T, Li G, Liang Y, et al. A wide spectrum of variability
periictal MRI abnormalities induced by a single or cluster of sei-
zures. J Neurol Sci. 2014;343:167–72.
21. Sabatini SJ, Feltrin FS, Rahal MA, et al. Neurophysiological and
neuroimaging changes (crossed cerebrocerebellar atrophy) after
prolonged non‐convulsive status epilepticus. Arq Neuropsiquiatr.
2016; 74(3):256–7.
22. Zaidi SA, Haq MA, Bindman D, et al. Crossed cerebellar diaschi-
sis: a radiological finding in status epilepticus not to miss. BMJ
Case Rep. 2013; 2013:bcr2013200478.
23. Meletti S, Slonkova J, Mareckova I, et al. Claustrum damage and
refractory status epilepticus following febrile illness. Neurology.
2015;85:1–9.
24. Goyal MK, Sinha S, Ravishankar S, et al. Peri‐ictal signal
changes in seven patients with status epilepticus: interesting MRI
observations. Neuroradiology. 2009;51:151–61.
25. Narayanan J. Can diffusion‐weighted imaging be used as a tool
to predict seizures in patients with PLEDS? Epileptic Disord.
2016;18:440–6.
26. Chatzikonstantinou A, Gass A, Förster A, et al. Features of acute
DWI abnormalities related to status epilepticus. Epilepsy Res.
2011;97:45–51.
27. Aellen J, Abela E, Buerki SE, et al. Focal hemodynamic patterns
of status epilepticus detected by susceptibility weighted imaging
(SWI). Eur Radiol. 2014;11:2980–8.
28. Nakae Y, Kudo Y, Yamamoto R, et al. Relationship between cor-
tex and pulvinar abnormalities on diffusion‐weighted imaging in
status epilepticus. J Neurol. 2016;263:127–32.
29. Grillo E. Postictal MRI abnormalities and seizure‐induced brain
injury: notions to be challenged. Epilepsy Behav. 2015;44:195–9.
30. Rennebaum F, Kassubek J, Pinkhardt E, et al. Status epilepticus:
clinical characteristics and EEG patterns associated with and
without MRI diffusion restriction in 69 patients. Epilepsy Res.
2016;120:55–64.
31. Di Bonaventura C, Bonini F, Fattouch J, et al. Diffusion‐
weighted magnetic resonance imaging in patients with partial sta-
tus epilepticus. Epilepsia. 2009;50(Suppl. 1):45–52.
How to cite this article: Giovannini G, Kuchukhidze
G, McCoy MR, Meletti S, Trinka E. Neuroimaging
alterations related to status epilepticus in an adult
population: Definition of MRI findings and clinical‐
EEG correlation. Epilepsia. 2018;00:1–8.
https://doi.org/10.1111/epi.14493
8 | GIOVANNINI ET AL.
